131 related articles for article (PubMed ID: 12767572)
1. Menopause rather than estrogen modifies plasma homocysteine levels.
Marchesoni D; Driul L; Plaino L; Villani MT; Becagli L; Mozzanega B
Int J Gynaecol Obstet; 2003 Jun; 81(3):293-7. PubMed ID: 12767572
[TBL] [Abstract][Full Text] [Related]
2. Effects of early initiated oestrogen replacement therapy on plasma homocysteine levels in women in surgically induced menopause.
Yüksel H; Cobanoğlu M; Odabaşi AR; Sezer SD; Küçük M; Serter M
Gynecol Endocrinol; 2011 Feb; 27(2):101-6. PubMed ID: 20504097
[TBL] [Abstract][Full Text] [Related]
3. Effect of non-oral estrogen on risk markers for metabolic syndrome in early surgically menopausal women.
Kilic S; Yilmaz N; Erdogan G; Aydin M; Tasdemir N; Doganay M; Batioglu S
Climacteric; 2010 Feb; 13(1):55-62. PubMed ID: 19591007
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.
Lacut K; Oger E; Abalain JH; Moineau MP; Mottier D;
Atherosclerosis; 2004 May; 174(1):173-80. PubMed ID: 15135267
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
[TBL] [Abstract][Full Text] [Related]
6. [The effect of estrogen deficiency, estrogen and estro-progestagene therapy on total plasma homocysteine and serum lipid peroxide levels in postmenopausal women].
Bednarek-Tupikowska G; Tupikowski K; Bidzińska B; Kuliczkowska J; Filus A; Milewicz A
Ginekol Pol; 2005 Sep; 76(9):687-92. PubMed ID: 16417079
[TBL] [Abstract][Full Text] [Related]
7. The effect of estradiol valerate and dienogest combination on serum homocysteine levels in postmenopausal women: a clinical trial.
Pirimoglu ZM; Aygun E; Dansuk R; Kucukercan I; Unal O; Turan C
Gynecol Endocrinol; 2005 Sep; 21(3):185-8. PubMed ID: 16335913
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study.
Kurtay G; Ozmen B
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):206-11. PubMed ID: 16814449
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine.
Os I; Os A; Sandset PM; Bølling S; Seljeflot I; Djurovic S; Westheim A
Cardiology; 2002; 98(1-2):6-12. PubMed ID: 12373040
[TBL] [Abstract][Full Text] [Related]
10. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
Castelo-Branco C; Casals E; Sanllehy C; Duran M; Fortuny A; Vanrell JA
J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134
[TBL] [Abstract][Full Text] [Related]
11. Effect of transdermal estrogen therapy on some vasoactive humoral factors and 24-h ambulatory blood pressure in normotensive postmenopausal women.
Zacharieva S; Atanassova I; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Aslanova N
Climacteric; 2002 Sep; 5(3):293-9. PubMed ID: 12419088
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the impact of oral versus transdermal estrogen on serum lipoproteins.
Erenus M; Kutlay K; Kutlay L; Pekin S
Fertil Steril; 1994 Feb; 61(2):300-2. PubMed ID: 8299786
[TBL] [Abstract][Full Text] [Related]
13. Intranasal 17beta-estradiol treatment and Vitamin B12, folate and homocysteine in menopause.
Harma M; Harma M; Kocyigit A; Yaltali T
Maturitas; 2005 Apr; 50(4):353-8. PubMed ID: 15780537
[TBL] [Abstract][Full Text] [Related]
14. Effects of estrogen and psychological stress on plasma homocysteine levels.
Farag NH; Barshop BA; Mills PJ
Fertil Steril; 2003 Feb; 79(2):256-60. PubMed ID: 12568831
[TBL] [Abstract][Full Text] [Related]
15. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
Weissberger AJ; Ho KK; Lazarus L
J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
[TBL] [Abstract][Full Text] [Related]
16. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
[TBL] [Abstract][Full Text] [Related]
17. Resting ECG is modified after oophorectomy and regresses with estrogen replacement therapy in premenopausal women.
De Leo V; la Marca A; Agricola E; Morgante G; Mondillo S; Setacci C
Maturitas; 2000 Jul; 36(1):43-7. PubMed ID: 10989241
[TBL] [Abstract][Full Text] [Related]
18. Effect of oral or transdermal hormone replacement therapy on homocysteine levels: a randomized clinical trial.
Bruschi F; Dal Pino D; Fiore V; Parazzini F; Di Pace R; Cesana BM; Melotti D; Crosignani PG
Maturitas; 2004 May; 48(1):33-8. PubMed ID: 15223106
[TBL] [Abstract][Full Text] [Related]
19. Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women?
Bukowska H; Stanosz S; Zochowska E; Millo B; Sieja K; Chełstowski K; Naruszewicz M
Metabolism; 2005 Jan; 54(1):72-8. PubMed ID: 15562383
[TBL] [Abstract][Full Text] [Related]
20. A randomized placebo-controlled study of the effect of transdermal vs. oral estradiol with or without gestodene on homocysteine levels.
Smolders RG; van der Mooren MJ; Teerlink T; Merkus JM; Kroeks MV; Franke HR; Stehouwer CD; Kenemans P
Fertil Steril; 2003 Feb; 79(2):261-7. PubMed ID: 12568832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
